Everolimus - Globe Thesis

Keyword [Everolimus] Result: 41 - 60 \| Page: 3 of 4
41.	The Research Of Everolimus Anti-cardial Fibrosis By Upregulating TET1 Protein
42.	Everolimus(RAD001) Ameliorates Vascular Cognitive Impairment By Regulating Microglia Polarization Via The MTORC1 Signaling Pathway
43.	The Mechanisms That Everolimus Enhances The Cisplatin-induced Cell Death Of Human Skin Squamous Carcinoma Cell Line COLO-16
44.	A Meta-Analysis Of Clinical Outcomes With Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Drug-Eluting Metallic Stent In Coronary Artery Diseases
45.	A Research Of The Mechanism Of NPRL2 Involved In The Drug Resistance Of Everolimus In Castration-resistant Prostate Cancer
46.	PLGA-fasudil/PLA-everolimus/PCL-simvastatin Vascular External Sheath Loaded Drugs Inhibits Long-term Vein Graft Failure
47.	The Correlation Between Single Nucleotide Polymorphism Of PI3K/Akt/mTOR Pathway Gene And The Toxicity Of Everolimus In Advanced Breast Cancer
48.	The Mechanism Of SHOC2 To Promote Breast Cancer Progression And Regulate The Sensitivity Of MTOR Inhitor For Breast Cancer
49.	The Relationship Between The Expression Level Of Rictor And Cell Sensitivity To MTOR Inhibitors And Its Molecular Mechanism
50.	Attenuation Of Everolimus-induced Cytotoxicity By A Protective Autophagic Pathway Involving ERK Activation In Renal Cell Carcinoma Cells
51.	The Application And Mechanism Of The Stress Nanoload System Based On The "Redox Switch" In Targeted Treatment Of Renal Cell Carcinoma
52.	Everolimus With Low-dose Calcineurin Inhibitor Regimens For Kidney Transplant Recipients:A Systematic Review And Meta-analysis
53.	Experimental Study On The Effect Of MTOR Inhibitor Everolimus Combined With Temozolomide On Autophagy In Malignant Glioma Cell
54.	Efficacy And Safety Of Everolimus Combined With Endocrine Therapy For Hormone Receptor-positive Advanced Breast Cancer:A Systematic Review
55.	CRISPR/Cas9 Screening And Identification Of New Everolimus Resistance Target MAGIX In Renal Cell Carcinoma
56.	Pharmacoeconomic Evaluation Of Everolimus Plus Exemestane In The Treatment Of Advanced Breast Cancer
57.	Mutational Analysis Of Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex And The Outcome Of Short-term Everolimus Therapy
58.	A Case Report Of P.Arg1138Ter Tuberous Sclerosis Complex Treated With Everolimus And Literature Review
59.	The Investigation Of Dnmt3a Gene In The Pathological Characteristics?prognosis And Everolimus Resistance In Renal Clear Cell Carcinoma
60.	The Reverse Effect Of Everolimus On Lapatinib Resistance In Breast Cancer And Its Molecular Mechanism
<<First <Prev Next> Last>> Jump to